Curetis Group Company Ares Genetics is Granted Key European Patent on Genetic Resistance Testing Patent broadly covers genetic biomarkers and...
Amsterdam, the Netherlands, and Holzgerlingen, Germany, July 2, 2019, 08:00 am CET - Curetis N.V. (the "Company" and, together with its...
- All proposed AGM resolutions approved by shareholders Amsterdam, the Netherlands, Holzgerlingen, Germany, and San Diego, CA, USA, June 28...
- Several scientific conference contributions outline benefits of U.S. FDA-cleared Unyvero LRT Application Cartridge in both endotracheal...
- Test shows overall weighted average sensitivity of 90.1% (94.7%) and overall weighted average specificity of 98.4% (97.9%) in prospective...
- Curetis and EIB agree on equity-linked participation upon maturity of new EUR 5 million tranche of debt...
Curetis Announces Financial Results for the First Three Months of 2019 - Total year-on-year revenue growth of approximately 45% - Successful...
Curetis to Hold Annual General Shareholders’ Meeting on June 27, 2019 Amsterdam, the Netherlands, Holzgerlingen, Germany and San Diego, CA...
Curetis / Curetis startet privat platzierte Kapitalerhöhung in Höhe von bis zu €18,4 Millionen . Verarbeitet und übermittelt durch West...
Curetis / Curetis, Beijing Clear Biotech Expand Strategic Collaboration for Unyvero in Greater China . Processed and transmitted by West...
Curetis / Curetis veröffentlicht Zwischenbericht für das erste Halbjahr 2018 . Verarbeitet und übermittelt durch West Corporation. Für den Inhalt...
Curetis / Curetis gibt Ergebnisse der Hauptversammlung vom 21. Juni 2018 bekannt . Verarbeitet und übermittelt durch Nasdaq Corporate...
Curetis / Curetis To Attend Key Investor and Scientific Conferences In The Third Quarter 2018 . Processed and transmitted by Nasdaq Corporate...
Curetis / Curetis gibt Teilnahme an Investoren- und Wissenschaftskonferenzen im dritten Quartal 2018 bekannt . Verarbeitet und übermittelt durch...
Curetis / Curetis berichtet über Geschäfts- und Finanzentwicklung im ersten Quartal 2018 . Verarbeitet und übermittelt durch Nasdaq Corporate...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Subscribe to Ad free and enjoy an ad-free experience
Try Now
Keep the Ads